Drospirenone And Ethinyl Estradiol Kit
Product Images NDC 31722-945

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Drospirenone And Ethinyl Estradiol (NDC 31722-945). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3blistercarton (3sblistercarton)

Packaging label for Drospirenone and Ethinyl Estradiol Tablets, USP 3 mg/0.03 mg kit by Camber Pharmaceuticals, Inc. The label indicates the product contains 3 blister cards of 28 tablets each, with information for prescribers and patients, storage instructions, and regulatory details. The label features barcodes and lot, serial, and expiration number fields.*

FDA Label Image

Camber (Camber)

FDA Label Image

Camber2 (Camber2)

FDA Label Image

Drosandeedosechart (Drosandeedosechart)

A vertical chart illustrating pregnancy rates per 100 women in one year categorized by birth control methods. The arrow ranges from fewer pregnancies at the top (fewer than 1 per 100) to more pregnancies at the bottom (85 or more per 100). Methods with fewer pregnancies include implants, injections, intrauterine devices, and sterilization. Mid-range effectiveness includes birth control pills, skin patch, and vaginal ring with hormones. Less effective methods listed are condoms and diaphragm, followed by no sex during fertile days, spermicide, and withdrawal. No birth control is associated with the highest pregnancy rates.*

FDA Label Image

Drosandeefig-1 (Drosandeefig 1)

A forest plot chart showing hazard ratios, rate ratios, and odds ratios from multiple studies, categorized as Prospective Cohort Studies, Retrospective Cohort Studies, Case-Control Studies, and Non-fatal idiopathic cases only. Each study is represented by a point estimate with a horizontal confidence interval line on a logarithmic scale from 0.1 to 10.*

FDA Label Image

Drosandeefig-2 (Drosandeefig 2)

A horizontal bar graph illustrating the number of women with a blood clot out of 10,000 women years for four groups: Non-Pregnant Non-COC users (range 1 to 5), COC-Users (range 3 to 9), Pregnancy (range 5 to 20), and Postpartum (12 weeks only) (range 40 to 65). The x-axis represents the number of women with a blood clot, and explanatory notes about pregnancy duration and data are included below the graph.*

FDA Label Image

Drospandeebloodclot (Drospandeebloodclot)

A horizontal bar chart depicting the number of women with a blood clot out of 10,000 woman years (WY) for four groups: Non-Pregnant Non-COC user (range 1 to 5), COC-User (range 3 to 9), Pregnancy (range 5 to 20), and Postpartum (12 weeks only) with the highest range of 40 to 65. The chart illustrates comparative blood clot incidence rates among these groups.*

FDA Label Image

Drospstructure (Drospstructure)

Chemical structure of the active ingredient shown in the image, which corresponds to Drospirenone and Ethinyl Estradiol, components of the human prescription drug kit by Camber Pharmaceuticals, Inc.*

FDA Label Image

Eestructure (Eestructure)

Chemical structure of Drospirenone and Ethinyl Estradiol active ingredients, showing the steroid framework with hydroxyl (OH) groups and an ethinyl group. The diagram labels carbon atoms and double bonds typical of these hormone molecules.*

FDA Label Image

Foil (Foil)

An illustrated dosing calendar for Drospirenone and Ethinyl Estradiol kit by Camber Pharmaceuticals, Inc., arranged in four rows representing weeks, with labeled circles for each day of the week (Sunday through Saturday) where patients can place day labels to track daily medication intake.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.